4//SEC Filing
Betterley Laurence L 4
Accession 0000914190-17-000245
CIK 0001180145other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:50 PM ET
Size
9.0 KB
Accession
0000914190-17-000245
Insider Transaction Report
Form 4
BETTERLEY LAURENCE L
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-08-15$30.76/sh−2,635$81,051→ 223,557 total - Sale
Common Stock
2017-08-16$30.72/sh−1,808$55,538→ 221,749 total
Holdings
- 14,234
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-01→ Common Stock (14,234 underlying)
Footnotes (4)
- [F1]In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.64 to $30.89 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.64 to $30.83 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Fully exercisable.
Documents
Issuer
Cardiovascular Systems Inc
CIK 0001180145
Entity typeother
Related Parties
1- filerCIK 0001243511
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:50 PM ET
- Size
- 9.0 KB